The influence of haemodialysis on CD4+ T-cell counts in people living with human immunodeficiency virus with end-stage kidney disease.

IF 1.6 4区 医学 Q4 INFECTIOUS DISEASES
Southern African Journal of Hiv Medicine Pub Date : 2020-12-21 eCollection Date: 2020-01-01 DOI:10.4102/sajhivmed.v21i1.1125
Melanie Pretorius, Estee Benade, June Fabian, Denise Lawrie, Elizabeth S Mayne
{"title":"The influence of haemodialysis on CD4+ T-cell counts in people living with human immunodeficiency virus with end-stage kidney disease.","authors":"Melanie Pretorius,&nbsp;Estee Benade,&nbsp;June Fabian,&nbsp;Denise Lawrie,&nbsp;Elizabeth S Mayne","doi":"10.4102/sajhivmed.v21i1.1125","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In South Africa it is estimated that 7.9 million people are living with human immunodeficiency virus (HIV). HIV is associated with an increased risk of kidney disease. For people living with HIV (PLWH) who develop end-stage kidney disease (ESKD), access to renal replacement therapy can be difficult. Kidney transplantation is a cost-effective option, with improved overall survival and better quality of life. In Johannesburg, the eligibility criteria for kidney transplantation include a sustained CD4+ T-cell count of > 200 cells/μL and suppressed HIV replication.</p><p><strong>Objective: </strong>To investigate the influence of haemodialysis on the lymphocyte subsets in PLWH with ESKD. In addition, all available %CD4+ T-cell counts, absolute CD4+ T-cell counts and viral load measurements were collected to assess the longitudinal trends of these measurements in PLWH with ESKD.</p><p><strong>Methods: </strong>This was a cross-sectional study comparing two groups. The HIV-infected study participants (<i>n</i> = 17) and HIV-uninfected controls (<i>n</i> = 17) were recruited from renal dialysis centres in Johannesburg from 2017 to 2018. Demographic data and social data were collected from all the study participants (<i>n</i> = 17). Blood samples were collected from all the study participants (before and after a haemodialysis session), and the lymphocyte subsets were then measured. The available longitudinal data for the serial CD4+ T-cell counts and HIV viral loads were collected (<i>n</i> = 14).</p><p><strong>Results: </strong>Our cohort showed a statistically significant increase in the post-dialysis percentage of CD4+ T cells (5%, <i>p</i> < 0.001) and the absolute CD4+ T-cell counts (21 cells/µL, <i>p</i> < 0.03). The longitudinal trend analysis for the percentage of CD4+ T cells revealed a significant increase in five participants (36%), and a single patient (7%) had a significant decrease in the longitudinal trend analysis for the absolute CD4+ T-cell counts. The longitudinal trend analysis for HIV viral load revealed the majority of our participants were not virologically suppressed.</p><p><strong>Conclusion: </strong>This study showed that haemodialysis does not have an immediate negative impact on CD4+ T-cell count, suggesting that immunologic recovery is not impeded by treatment of the underlying ESKD.</p>","PeriodicalId":49489,"journal":{"name":"Southern African Journal of Hiv Medicine","volume":" ","pages":"1125"},"PeriodicalIF":1.6000,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756925/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Hiv Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4102/sajhivmed.v21i1.1125","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In South Africa it is estimated that 7.9 million people are living with human immunodeficiency virus (HIV). HIV is associated with an increased risk of kidney disease. For people living with HIV (PLWH) who develop end-stage kidney disease (ESKD), access to renal replacement therapy can be difficult. Kidney transplantation is a cost-effective option, with improved overall survival and better quality of life. In Johannesburg, the eligibility criteria for kidney transplantation include a sustained CD4+ T-cell count of > 200 cells/μL and suppressed HIV replication.

Objective: To investigate the influence of haemodialysis on the lymphocyte subsets in PLWH with ESKD. In addition, all available %CD4+ T-cell counts, absolute CD4+ T-cell counts and viral load measurements were collected to assess the longitudinal trends of these measurements in PLWH with ESKD.

Methods: This was a cross-sectional study comparing two groups. The HIV-infected study participants (n = 17) and HIV-uninfected controls (n = 17) were recruited from renal dialysis centres in Johannesburg from 2017 to 2018. Demographic data and social data were collected from all the study participants (n = 17). Blood samples were collected from all the study participants (before and after a haemodialysis session), and the lymphocyte subsets were then measured. The available longitudinal data for the serial CD4+ T-cell counts and HIV viral loads were collected (n = 14).

Results: Our cohort showed a statistically significant increase in the post-dialysis percentage of CD4+ T cells (5%, p < 0.001) and the absolute CD4+ T-cell counts (21 cells/µL, p < 0.03). The longitudinal trend analysis for the percentage of CD4+ T cells revealed a significant increase in five participants (36%), and a single patient (7%) had a significant decrease in the longitudinal trend analysis for the absolute CD4+ T-cell counts. The longitudinal trend analysis for HIV viral load revealed the majority of our participants were not virologically suppressed.

Conclusion: This study showed that haemodialysis does not have an immediate negative impact on CD4+ T-cell count, suggesting that immunologic recovery is not impeded by treatment of the underlying ESKD.

Abstract Image

Abstract Image

血液透析对人类免疫缺陷病毒终末期肾病患者CD4+ t细胞计数的影响
背景:在南非,估计有790万人感染了人类免疫缺陷病毒(HIV)。艾滋病毒与肾脏疾病的风险增加有关。对于患有终末期肾病(ESKD)的艾滋病毒感染者(PLWH)来说,获得肾脏替代疗法可能很困难。肾移植是一种经济有效的选择,可以提高总体存活率和生活质量。在约翰内斯堡,肾移植的合格标准包括持续的CD4+ t细胞计数> 200细胞/μL和抑制HIV复制。目的:探讨血液透析对合并ESKD的PLWH患者淋巴细胞亚群的影响。此外,收集所有可用的%CD4+ t细胞计数、绝对CD4+ t细胞计数和病毒载量测量值,以评估这些测量值在ESKD PLWH中的纵向趋势。方法:采用横断面研究方法,对两组进行比较。艾滋病毒感染的研究参与者(n = 17)和未感染艾滋病毒的对照组(n = 17)于2017年至2018年从约翰内斯堡的肾透析中心招募。收集所有研究参与者的人口统计资料和社会资料(n = 17)。从所有研究参与者(血液透析前后)收集血液样本,然后测量淋巴细胞亚群。收集序列CD4+ t细胞计数和HIV病毒载量的可用纵向数据(n = 14)。结果:我们的队列显示透析后CD4+ T细胞百分比(5%,p < 0.001)和CD4+ T细胞绝对计数(21个细胞/µL, p < 0.03)有统计学意义的增加。CD4+ T细胞百分比的纵向趋势分析显示,5名参与者(36%)的CD4+ T细胞百分比显著增加,1名患者(7%)的CD4+ T细胞绝对计数的纵向趋势分析显著减少。HIV病毒载量的纵向趋势分析显示,我们的大多数参与者没有受到病毒学抑制。结论:本研究表明血液透析不会对CD4+ t细胞计数产生直接的负面影响,这表明免疫恢复不会受到潜在ESKD治疗的阻碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
11.80%
发文量
41
审稿时长
>12 weeks
期刊介绍: The Southern African Journal of HIV Medicine is focused on HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice. The purpose of the journal is to disseminate original research results and to support high-level learning related to HIV Medicine. It publishes original research articles, editorials, case reports/case series, reviews of state-of-the-art clinical practice, and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信